N/A
N=241
Telepsychology-Service Delivery for Depressed Elderly Veterans
Depression · Elderly
Bottom Line
View on ClinicalTrials.gov: NCT00324701 ↗Enrolled (actual)
241
Serious AEs
0.0%
Results posted
Nov 2014
Primary outcome: Primary: At Least a 50% Improvement From Baseline to Post-treatment on the Geriatric Depression Scale (GDS) — 17.6; 22.4; 22.0; 20.2 % participants with treatment response
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Telepsychology (Behavioral); Face-to-face therapy (Behavioral)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Jul 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY At Least a 50% Improvement From Baseline to Post-treatment on the Geriatric Depression Scale (GDS) |
17.6; 22.4; 22.0; 20.2 | — |
| SECONDARY SCID: Structured Clinical Interview for the DSM-IV |
50; 44.2 | — |
Summary
The purpose of this study is to see whether therapy for elderly adults with major depression can be delivered effectively using videoconferencing technology ("telepsychology"), which allows a therapist and patient who are not in the same room as one another to communicate. We are interested in learning if this form of mental health service delivery is an acceptable alternative to traditional face-to-face therapy delivered with the therapist in the same room as the patient.
Eligibility Criteria
Inclusion Criteria
- Participants will be older male and female veterans,
- age 60 and above,
- with diagnoses of major depressive disorder (MDD) assigned on the basis of the Structured Clinical Interview for DSM-IV (SCID; Spitzer et al., 1997).
Exclusion Criteria
- Actively psychotic or demented persons,
- individuals with both suicidal ideation and clear intent, and
- individuals meeting criteria for substance dependence will be excluded from participation.
However, in order to maximize generalization of results, presence of other forms of psychopathology will not be a basis for exclusion. All of these structured interviews will be audiotaped in order to calculate inter-rater reliability on a randomly selected 20%. (See Human Subjects for procedures in place for suicidal participants or potential participants).
Data sourced from ClinicalTrials.gov (NCT00324701). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.